Peter Keeling of Diaceutics
In the Company of Mavericks
00:00
DXRX Is the Direction of Travel for Us in DASIS
The direction of travel for us in DASIS is absolutely to have our therapy teams plug into DASISIS or rather we plug into them and put it the other way around. Plugging in means we start that journey with them two years before they launch the drug and stay with them for five years after they've launched the drug. And so it naturally lends itself to plugging in to those therapy teams. So from a custom point of view, we think that's the right way to go. The difficulty is you have to have a sufficient supply and product innovation in order to create that level of subscriptions.
Transcript
Play full episode
